Table 2.
Kit’s Description | Manufacturer | Whole Blood Specimens Volume | Pretreatment Method |
Detection Limit | Species | Reference |
---|---|---|---|---|---|---|
Automatic kits | ||||||
EZ1TM DNA Tissue Kit * | Qiagen | 200 μL | - | 1400 ng/μL | C.glabrata | [38] |
EZ1TM DNA Tissue Kit * | Qiagen | 200 μL | N2 | 570 ng/μL | C.glabrata | [38] |
NucliSENSTM EasyMAGTM * | Fisher Scientific | 200 µL | CB LB |
10 CFU/mL Ct < 20 |
C. albicans C.glabrata C.parapsilosis C.tropicalis C. krusei |
[43] |
EZ1TM DNA Blood 200 µL Kit * | Qiagen | 200 µL | - | 106 CFU/mL | [43] | |
EZ1TM DNA Blood 200 µL Kit * | Qiagen | 200 µL | CB LB |
10 CFU/mL Ct < 20 | [43] | |
EZ1TM DNA Tissue Kit * | Qiagen | 190 µL | LyT | 10 CFU/mL Ct < 20 | [43] | |
EZ1TM DNA Tissue Kit * | Qiagen | 100μL−1 mL | - | 103 CFU/mL | C. albicans | [44] |
EZ1TM DNA Tissue Kit * | Qiagen | 100μL−1 mL | TTE LyS LyT |
102 CFU/mL | C. albicans | [44] |
QIAampTM 96DNA QIAcube HT kit * | Qiagen | 200 μL | - | 106 CFU/mL |
C. albicans
C.glabrata C.parapsilosis C.tropicalis C. krusei |
[43] |
Macherey-Nagel™ Pathogène NucleoMag™ * | BioMérieux | 150 μL | - | 106 CFU/mL | [43] | |
Mag-BindTM Viral DNA/RNA kit * | Omega Bio-tek | 200 μL | - | 106 CFU/mL | [43] | |
MagMAX™ Viral/ PathogenNucleic Acid Isolation Kit * |
Applied Biosystems MGISP |
400 μL | - | 106 CFU/mL | [43] | |
Chemagic Viral DNA/RNA 300 kit H96 * | PerkinElmer | 200 μL | - | 106 CFU/mL | [43] | |
Virus DNA/RNA Extraction Kit * | MGI | 200 μL | - | 106 CFU/mL | [43] | |
BioextractTM SuperballTM kit * | Biosellal | 200 μL | - | 106 CFU/mL | [43] | |
Maxwell 16 Cell LEV DNA Purification Kit * | Promega Co. | 100μL−1 mL | - | 102 CFU/mL | C. albicans | [44] |
Maxwell 16 Cell LEV DNA Purification Kit * | Promega Co. | 100μL−1 mL | TTE LyS LyT |
102 CFU/mL | C. albicans | [44] |
Maxwell 16 Blood DNA Purification Kit * | Promega Co. | 100μL−1 mL | - | 106 CFU/mL | C. albicans | [44] |
Maxwell 16 Blood DNA Purification Kit * | Promega Co. | 100μL−1 mL | TTE LyS LyT |
102 CFU/mL | C. albicans | [44] |
Manual kits | ||||||
DNeasy Blood and Tissue * | Qiagen | 100μL−1 mL | - | Not detected | C. albicans | [44] |
DNeasy Blood and Tissue * | Qiagen | 100μL−1 mL | TTE Ammonium chloride LyS LyT Bead Beating |
102 CFU/mL | C. albicans | [44] |
QIAamp DNA Blood Min i * | Qiagen | 100μL−1 mL | - | 106 CFU/mL | C. albicans | [44] |
QIAamp DNA Blood Mini * | Qiagen | 100μL−1 mL | LyS LyT Bead Beating |
102 CFU/mL | C. albicans | [44] |
PureLink Genomic DNA Mini * | Invitrogen Co | 100μL−1 mL | - | 106 CFU/mL | C. albicans | [44] |
PureLink Genomic DNA Mini * | Invitrogen Co | 100μL−1 mL | LyS LyT |
106 CFU/mL | C. albicans | [44] |
High Pure PCR Template Preparation * | Roche Inc. | 100μL−1 mL | - | 106 CFU/mL | C. albicans | [44] |
High Pure PCR Template Preparation * | Roche Inc. | 100μL−1 mL | LyS LyT |
103 CFU/mL | C. albicans | [44] |
UMD-Universal CE IVD * | Molzym GmbH & Co. | 100μL−1 mL | - | 101 CFU/mL | C. albicans | [44] |
QIAamp DNA mini kit * | Qiagen | 2 µL | - | < 10 ng/μL |
Candida spp.:
C. albicans C. glabrata C. parapsilosis C. tropicalis C. famata C. krusei C. dubliniensis C. haemulonii |
[41] |
QIAamp DNA mini kit * | Qiagen | 2 µL | SDS β-mercaptoethanol |
20 ng/μL | [41] | |
QIAamp DNA mini kit * | Qiagen | 2 µL | glass beads | 198 ± 18.9 ng/μL | [41] | |
Chelex-100/boiling | Not commercial | 200 μL | - | 104 CFU/mL | C. albicans | [45] |
In-house protocol * | Not commercial | 50–100 µL | guanidinium thiocyanate acid PK |
260 CFU/mL (whole blood) 200 CFU/mL (serum) |
C. albicans | [46] |
QIAamp DNA Blood Mini * | Qiagen | 1 mL | Polaris (Biocartis) enrichement LB |
1 CFU/mL Ct < 35 |
C. albicans | [47] |
QIAamp DNA Blood Mini * | Qiagen | 5 mL | Polaris (Biocartis) enrichement LB |
1 CFU/mL Ct < 35 |
C. albicans | [47] |
In-house protocol ** | - | 3 mL | TTE SDS potasium acetate centrifugation cold ethanol |
1–10 CFU/mL | C. albicans | [48] |
GeneReleaser ** | Eurogentec | 3 mL | LB SDS TTE β-mercaptoethanol |
1–10 CFU/mL |
C. albicans | [48] |
QIAamp Tissue ** | Qiagen | 3 mL | LB SDS TTE β-mercaptoethanol |
10 CFU/mL | C. albicans | [48] |
PureGene D 6000 ** | Gentra | 3 mL | LB SDS TTE β-mercaptoethanol |
102 CFU/mL |
C. albicans | [48] |
DNAzol ** | Sigma | 3 mL | LB SDS TTE β-mercaptoethanol |
103 CFU/mL | C. albicans | [48] |
PKPC | Not commercial | 400 μL | PK PC TTE |
103 CFU/mL | Candida spp. | [49] |
HLGT | Not commercial | 400 μL | guanidine thiocyanate acid heat lysis |
10 CFU/mL | Candida spp. | [49] |
QIAamp DNA Blood * | Qiagen | 400 μL | - | 10 CFU/mL |
Candida spp. | [49] |
High Pure PCR Template Preparation * | Roche Inc. | 400 μL | - | 102 CFU/mL |
Candida spp. | [49] |
DNAzol * | Sigma | 400 μL | - | 104 CFU/mL |
Candida spp. | [49] |
QIAamp DNA mini kit * | Qiagen | 1 mL | LyT | 96 ± 21 | C. albicans | [31] |
QIAamp DNA mini kit * | Qiagen | 1 mL | glass beads | 89 ± 44 | C. albicans | [31] |
MasterPure yeast DNA purification kit * | Epicentre | 1 mL | TTE | 215 ± 109 | C. albicans | [31] |
BAGH * | Not commercial | 1 mL | benzyl alcohol guanidine hydrochloride TTE |
33 ± 42 | C. albicans | [31] |
Dr GenTle (gene trapping by liquid extraction) * | Takara Bio | 1 mL | TTE | 36 ± 18 | C. albicans | [31] |
yeast DNA extraction reagent (Y-DER) * | Pierce Biotechnology | 1 mL | TTE | 23 ± 10 | C. albicans | [31] |
YeaStar genomic DNA kit * | Zymo Research | 1 mL | TTE | 11 ± 4 | C. albicans | [31] |
TTE = Triton-Tris-EDTA (20 mM Tris-HCl [pH 8.3], 1 mM EDTA, and 1% Triton), PK = proteinase K, LyS = lysozyme, LyT = lyticase, CB = ceramic beads, LB = lysis buffer, N2= liquid nitrogen maceration. * the study involved blood samples from healthy patients spiked with fungal cells, ** samples from neutropenic patients suspected or diagnosed with systemic candidiasis.